Shiro Akinaga

Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study

Takashi Ishida, Tatsuro Joh, Naokuni Uike et al. · Journal of Clinical Oncology · 2012 · 639 citations · Full text

Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin

Theodor W. Schulte, Shiro Akinaga, Shiro Soga et al. · Cell Stress and Chaperones · 1998 · 399 citations · Full text

Medicine, N-terminal Domain, Molecular Biology +5

Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma

Michinori Ogura, Takashi Ishida, Kiyohiko Hatake et al. · Journal of Clinical Oncology · 2014 · 357 citations · Full text

Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma

Kazuhito Yamamoto, Atae Utsunomiya, Kensei Tobinai et al. · Journal of Clinical Oncology · 2010 · 350 citations · Full text

Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents.

Rochelle Bagatell, Gillian Paine-Murrieta, Charles W. Taylor et al. · PubMed · 2000 · 273 citations

Apoptosis, Cell Death, Cytotoxic Activity +17